Clinical Trial Update: Phase II Avastin Trial for Stage IIIB/IV NSCLC [Phase 2]

View source ↗

Summary

A Phase II trial of Avastin (bevacizumab) for stage IIIB/IV non-small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Pharmatech | Conditions: Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV | Phase 2 | Status: TERMINATED